Keywords: شاپرن فارماکولوژیک; ALKs; activin receptor-like (type I) kinases; BMP; bone morphogenetic protein; BMPRII; BMP type II receptor; FKBP12; FK506-binding protein 12â¯kDa; FOP; Fibrodysplasia Ossificans Progressiva; AMPK; AMP-activated protein kinase; SMKI; small molecule kinas
مقالات ISI شاپرن فارماکولوژیک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: شاپرن فارماکولوژیک; GBA; Glucocerebrosidase; MD; Molecular Dynamics; GD; Gaucher Disease; PC; Pharmacological Chaperone; SP; Standard Precision; XP; Extra Precision; GBA; Gaucher disease; Molecular docking; Substructure search; Molecular dynamics; Blood brain barrier; Pharma
Keywords: شاپرن فارماکولوژیک; BH4; tetrahydrobiopterin; DSF; differential scanning fluorimetry; L-Dopa; (S)-3,4-dihydroxyphenylalanine; PAH; phenylalanine hydroxylase; PKU; phenylketonuria; TH; tyrosine hydroxylase; THD; TH deficiency; TPH2; tryptophan hydroxylase isoform 2; PD; Parki
Keywords: شاپرن فارماکولوژیک; Fabry disease; Lysosomal storage disorders; Pharmacological chaperone; α-Galactosidase A; Globotriaosylceramide;
Keywords: شاپرن فارماکولوژیک; DAH7PS; 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase; IEC; ion exchange chromatography; MBP; maltose binding protein; PS; Phenyl Sepharose; Phe; phenylalanine; PAH; phenylalanine hydroxylase; PKU; phenylketonuria; PAGE; polyacrylamide gel electrop
A new type of pharmacological chaperone for GM1-gangliosidosis related human lysosomal β-galactosidase: N-Substituted 5-amino-1-hydroxymethyl-cyclopentanetriols
Keywords: شاپرن فارماکولوژیک; Aminocyclopentane; Carbafuranose; Galactosidase inhibitor; Pharmacological chaperone; GM1-Gangliosidosis;
Rapid preparation of (3R,4S,5R) polyhydroxylated pyrrolidine-based libraries to discover a pharmacological chaperone for treatment of Fabry disease
Keywords: شاپرن فارماکولوژیک; Azasugar; Polyhydroxylated pyrrolidine; Fabry disease; Pharmacological chaperone; Combinatorial chemistry; Lysosomal α-galactosidase;
In silico analyses of the effects of a point mutation and a pharmacological chaperone on the thermal fluctuation of phenylalanine hydroxylase
Keywords: شاپرن فارماکولوژیک; Phenylalanine hydroxylase; Pharmacological chaperone; Molecular dynamics simulation; Thermal fluctuation;
A Morita-Baylis-Hillman based route to C-5a-chain-extended 4-epi-isofagomine type glycosidase inhibitors
Keywords: شاپرن فارماکولوژیک; Morita-Baylis-Hillman reaction; 4-epi-isofagomine; Glycosidase inhibitor; Pharmacological chaperone;
N-Substituted 5-amino-1-hydroxymethyl-cyclopentanetriols: A new family of activity promotors for a GM1-gangliosidosis related human lysosomal β-galactosidase mutant
Keywords: شاپرن فارماکولوژیک; Aminocyclopentane; Carbafuranose; Galactosidase inhibitor; Pharmacological chaperone; GM1-Gangliosidosis;
Targeting chaperones, heat shock factor-1, and unfolded protein response: Promising therapeutic approaches for neurodegenerative disorders
Keywords: شاپرن فارماکولوژیک; 17-AAG; 17-(allylamino)-17-demethoxygeldanamycin (tanespimycin); 17-DMAG; 17- dimethylaminoethylamino-17-demethoxygeldanamycin (alvespimycin); AAV; adeno-associated virus; Aβ; amyloid-β; AD; Alzheimer's disease; ALS; amyotrophic lateral sclerosis; APP;
Synthesis of C-5a-chain extended derivatives of 4-epi-isofagomine: Powerful β-galactosidase inhibitors and low concentration activators of GM1-gangliosidosis-related human lysosomal β-galactosidase
Keywords: شاپرن فارماکولوژیک; Iminoalditol; 4-epi-Isofagomine; Galactosidase inhibitor; Pharmacological chaperone; GM1-gangliosidosis
5-Fluoro derivatives of 4-epi-isofagomine as d-galactosidase inhibitors and potential pharmacological chaperones for GM1-gangliosidosis as well as Fabry's disease
Keywords: شاپرن فارماکولوژیک; Iminoalditol; Fluorosugar; Galactosidase inhibitor; Pharmacological chaperone; Fabry's disease; GM1-gangliosidosis
Bioevaluation of sixteen ADMDP stereoisomers toward alpha-galactosidase A: Development of a new pharmacological chaperone for the treatment of Fabry disease and potential enhancement of enzyme replacement therapy efficiency
Keywords: شاپرن فارماکولوژیک; Fabry disease; Lysosomal α-galactosidase A; Lysosomal storage diseases; Enzyme replacement therapy; Pharmacological chaperone; Pyrrolidine-based iminosugar;
Synthesis of C-5a-substituted derivatives of 4-epi-isofagomine: notable β-galactosidase inhibitors and activity promotors of GM1-gangliosidosis related human lysosomal β-galactosidase mutant R201C
Keywords: شاپرن فارماکولوژیک; Iminoalditol; 4-Epi-isofagomine; Galactosidase inhibitor; Pharmacological chaperone; GM1-gangliosidosis;
Inhibitor versus chaperone behaviour of d-fagomine, DAB and LAB sp2-iminosugar conjugates against glycosidases: A structure-activity relationship study in Gaucher fibroblasts
Keywords: شاپرن فارماکولوژیک; Iminosugar; d-Fagomine; Pyrrolidine; Glycosidase inhibitor; Pharmacological chaperone; Gaucher disease;
The non-detergent sulfobetaine-201 acts as a pharmacological chaperone to promote folding and crystallization of the type II TGF-β receptor extracellular domain
Keywords: شاپرن فارماکولوژیک; Non-detergent sulfobetaine 201; Transforming growth factor β; Type II transforming growth factor β receptor; Protein folding; Pharmacological chaperone;
Conformationally-locked N-glycosides: Exploiting long-range non-glycone interactions in the design of pharmacological chaperones for Gaucher disease
Keywords: شاپرن فارماکولوژیک; Glycomimetic; Glycosidase inhibitor; Pharmacological chaperone; Gaucher disease; Glucocerebrosidase; Lysosomal storage disorders
Structure-activity relationships of oxysterol-derived pharmacological chaperones for Niemann-Pick type C1 protein
Keywords: شاپرن فارماکولوژیک; Niemann-Pick disease type C; NPC1; Pharmacological chaperone; Oxysterol; Structure-activity relationships;
Using pharmacological chaperones to restore proteostasis
Keywords: شاپرن فارماکولوژیک; NN-DNJ (PubChem CID: 501640); E4031 (PubChem CID: 3185); Nicotine (PubChem CID: 89594); GABA (PubChem CID: 119); SR121463 (PubChem CID: 9810773); Naltrexone (PubChem CID: 5360515); Pharmacological chaperone; Proteostasis; Chaperone; ERAD; Protein misfoldi
Docking and SAR studies of calystegines: Binding orientation and influence on pharmacological chaperone effects for Gaucher’s disease
Keywords: شاپرن فارماکولوژیک; Calystegine; nor-Tropane alkaloids; Gaucher’s disease; β-Glucocerebrosidase; Molecular docking study; Binding orientation; Pharmacological chaperone
Pharmacological chaperoning: A primer on mechanism and pharmacology
Keywords: شاپرن فارماکولوژیک; Pharmacological chaperone; Pharmacoperone; Chaperoning; Misfolding mutant; Rescue; GPCR; Endoplasmic reticulum; Calnexin; Protein folding disorders;
Pharmacological chaperoning of nAChRs: A therapeutic target for Parkinson's disease
Keywords: شاپرن فارماکولوژیک; Pharmacological chaperone; Chaperoning; Nicotine; nAChR; Tobacco; Neuroprotection; Parkinson's disease; Neurodegeneration; Unfolded protein response; Dopaminergic; Endoplasmic reticulum stress; FRET; TIRF; Confocal; ER exit sites; Golgi; Ligand; COPII; CO
A thermodynamic assay to test pharmacological chaperones for Fabry disease
Keywords: شاپرن فارماکولوژیک; PC; pharmacological chaperones; FD; Fabry disease; AGAL; lysosomal alpha-galactosidase; DGJ; 1-deoxy-galactonojirimycin; CD; circular dichroism; Pharmacological chaperone; Lysosomal storage disorder; Urea-induced unfolding; Limited proteolysis; Cell lysat
Selective chaperone effect of aminocyclitol derivatives on G202R and other mutant glucocerebrosidases causing Gaucher disease
Keywords: شاپرن فارماکولوژیک; BBB; blood-brain barrier; CBE; conduritol β-epoxide; Cer; ceramide; D-MEM; Dulbeco Eagle's minimal essential medium; ERT; enzyme replacement therapy; GBA1; lysosomal glucocerebrosidase; GBA2; non-lysosomal glucocerebrosidase; GlcCer; glucosylceramide;
Structure–activity relationship study of non-steroidal NPC1L1 ligands identified through cell-based assay using pharmacological chaperone effect as a readout
Keywords: شاپرن فارماکولوژیک; Niemann-Pick type C1-like 1; Cholesterol; Pharmacological chaperone; Non-steroidal ligands; Inhibitors; Structure–activity relationship
Use of Kikume green–red fusions to study the influence of pharmacological chaperones on trafficking of G protein-coupled receptors
Keywords: شاپرن فارماکولوژیک; Photoconvertible fluorescent proteins; G protein-coupled receptor; Vasopressin V2 receptor; Pharmacological chaperone; Post-translational rescue; Co-translational rescue
A fluorescent probe for GM1 gangliosidosis related β-galactosidase: N-(Dansylamino)hexylaminocarbonylpentyl-1,5-dideoxy-1,5-imino-d-galactitol
Keywords: شاپرن فارماکولوژیک; Iminoalditols; d-Galactosidase inhibitor; GM1 gangliosidosis; Pharmacological chaperone; Fluorescent probe
Proteasome inhibitors improve the function of mutant lysosomal α-glucosidase in fibroblasts from Pompe disease patient carrying c.546G>T mutation
Keywords: شاپرن فارماکولوژیک; Pompe disease; Bortezomib; MG132; Proteasome inhibitor; Pharmacological chaperone;
Molecular mechanism for stabilization of a mutant α-galactosidase A involving M51I amino acid substitution by imino sugars
Keywords: شاپرن فارماکولوژیک; α-Galactosidase A; Fabry disease; Pharmacological chaperone; Imino sugar; Molecular interaction
Endoplasmic reticulum stress induces autophagy through activation of p38 MAPK in fibroblasts from Pompe disease patients carrying c.546G>T mutation
Keywords: شاپرن فارماکولوژیک; Pompe disease; Endoplasmic reticulum stress; Autophagy; NB-DNJ; p38; Pharmacological chaperone;
Docking and SAR studies of d- and l-isofagomine isomers as human β-glucocerebrosidase inhibitors
Keywords: شاپرن فارماکولوژیک; Isofagomine; Fagomine; Structure–activity relationships; Molecular docking study; β-Glucocerebrosidase; Glycosidase inhibitor; Pharmacological chaperone
2,5-Dideoxy-2,5-imino-d-altritol as a new class of pharmacological chaperone for Fabry disease
Keywords: شاپرن فارماکولوژیک; Adenophora triphylla; 2,5-Dideoxy-2,5-imino-d-altritol; α-Galactosidase A; Pharmacological chaperone; Glycosidase inhibitor
DLHex-DGJ, a novel derivative of 1-deoxygalactonojirimycin with pharmacological chaperone activity in human GM1-gangliosidosis fibroblasts
Keywords: شاپرن فارماکولوژیک; β-Galactosidase; GM1-Gangliosidosis; Morquio B disease; DLHex-DGJ; Enzyme enhancement therapy; Pharmacological chaperone
Importance of extracellular loop one of the neuropeptide S receptor for biogenesis and function
Keywords: شاپرن فارماکولوژیک; Neuropeptide S; GPCR; Extracellular loop one; Biogenesis; Mutagenesis; Pharmacological chaperone;
Isofagomine increases lysosomal delivery of exogenous glucocerebrosidase
Keywords: شاپرن فارماکولوژیک; Pharmacological chaperone; Gaucher disease; Lysosomal storage disorders; Glucocerebrosidase; Molecular chaperone; Molecular mechanisms of pharmacological action; Enzyme replacement therapy
Partial trypsin digestion as an indicator of mis-folding of mutant alanine:glyoxylate aminotransferase and chaperone effects of specific ligands. Study of a spectrum of missense mutants
Keywords: شاپرن فارماکولوژیک; Hyperoxaluria; Mutation; Mis-folding; Pharmacological chaperone; Alanine:glyoxylate aminotransferase
In vitro inhibition of glycogen-degrading enzymes and glycosidases by six-membered sugar mimics and their evaluation in cell cultures
Keywords: شاپرن فارماکولوژیک; Six-membered sugar mimics; Glycogen phosphorylase; Amylo-1,6-glucosidase; Hepatocytes; Caco-2; Pharmacological chaperone; Noncompetitive inhibitor
Regulation of G protein-coupled receptor export trafficking
Keywords: شاپرن فارماکولوژیک; G protein-coupled receptor; Intracellular trafficking; Export; Sorting and targeting; Biosynthesis; Endoplasmic reticulum; Golgi; Folding; ER export motif; ER retention motif; ER chaperone; Chemical chaperone; Pharmacological chaperone; GPCR-interacting p
α-1-C-Octyl-1-deoxynojirimycin as a pharmacological chaperone for Gaucher disease
Keywords: شاپرن فارماکولوژیک; Gaucher disease; Pharmacological chaperone; β-Glucocerebrosidase inhibitor